Picture of Torrent Pharmaceuticals logo

TORNTPHARM — Torrent Pharmaceuticals News Story

0.000.00%
in flag iconLast trade - 00:00
HealthcareConservativeLarge CapHigh Flyer

Brief: Torrent Pharma Says USFDA Conducted Routine GMP Inspection Of Formulation Manufacturing Facility

Sept 20 (Reuters) - Torrent Pharmaceuticals Ltd
 TORP.NS :
    * USFDA CONDUCTED ROUTINE GMP INSPECTION OF FORMULATION
MANUFACTURING FACILITY
    * END OF INSPECTION, AGENCY ISSUED FORM FDA 483 WITH ONE
OBSERVATION
    * FORM FDA 483 WITH ONE OBSERVATION IS PROCEDURAL IN NATURE

Source text for Eikon:  ID:nBSE9Dt3XX 
Further company coverage:  TORP.NS 

 ((Reuters.Briefs@thomsonreuters.com;;))

Recent news on Torrent Pharmaceuticals

See all news